91
Carboplatin in Castration-resistant Prostate Cancer
Condition(s):Prostatic NeoplasmLast Updated:January 23, 2020Terminated
Metastatic Prostate Carcinoma in the Soft Tissue: 133 Clinical Trials, Page 10 of 14
Hide Studies Not Open or Pending
92
Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abiraterone
Condition(s):Metastatic Prostate Cancer; Castration-resistant Prostate Cancer; Prostatic Neoplasm; Cancer of the Prostate; Progressive mCRPCLast Updated:March 16, 2021Recruiting
93
Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed
Condition(s):Prostate Cancer; Prostatic Neoplasm; Urogenital Neoplasms; Prostatic Disease; Disease Attributes; NeoplasmsLast Updated:September 17, 2020Recruiting
94
Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer
Condition(s):Prostate CancerLast Updated:July 8, 2020Completed
95
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CC-94676 in Subjects With Metastatic Castration-Resistant Prostate Cancer
Condition(s):Prostatic NeoplasmsLast Updated:January 13, 2021Recruiting
96
Abiraterone-Rechallenge Study for CRPC Patients
Condition(s):Prostate CancerLast Updated:March 24, 2017Terminated
97
BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)
Condition(s):Prostatic Neoplasms, Castration-ResistantLast Updated:April 9, 2021Active, not recruiting
98
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
Condition(s):Prostatic NeoplasmsLast Updated:April 12, 2021Recruiting
99
National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
Condition(s):Prostate Cancer MetastaticLast Updated:February 12, 2020Recruiting
100
Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)
Condition(s):Prostatic NeoplasmsLast Updated:April 12, 2021Recruiting